Pfizer's Paxlovid reduces COVID risk in seniors regardless of vaccine status -study
Use of Pfizer's pills, authorized to treat newly infected, at-risk people in order to prevent severe illness, has soared in the United States.
Coronavirus disease (COVID-19) treatment pill Paxlovid is seen in a box, at Misericordia hospital in Grosseto, Italy, February 8, 2022.(photo credit: REUTERS/JENNIFER LORENZINI/FILE PHOTO)
